Company Filing History:
1 out of 15 
1 out of 4 
1 out of 30 Years Active: 2020
Title: Carmen Gómez Guerrero: Innovator in Diabetes Research
Introduction
Carmen Gómez Guerrero is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of diabetes research, particularly in developing innovative solutions for chronic complications associated with the disease. Her work focuses on the application of peptides derived from SOCS1 to address various complications arising from diabetes.
Latest Patents
Carmen holds a patent for a SOCS1-derived peptide intended for use in chronic complications of diabetes. This invention specifically targets ocular, renal, nerve, and vascular complications. The patent also encompasses compositions containing the peptide and isolated polynucleotides encoding it. Furthermore, the SOCS1-derived peptide is designed for topical use in treating and preventing neurodegenerative diseases of the retina, especially in the early stages of diabetic retinopathy and other retinal diseases where neurodegeneration is a critical factor. She has 1 patent to her name.
Career Highlights
Throughout her career, Carmen has worked with esteemed institutions such as Fundació Hospital Universitari Vall D'Hebron - Institut De Recerca and Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz. These affiliations have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Carmen has collaborated with notable professionals, including Jesús Egido De Los Rios and Rafael Simó Canonge. Their joint efforts have further advanced the understanding and treatment of diabetes-related complications.
Conclusion
Carmen Gómez Guerrero is a trailblazer in diabetes research, with her innovative work paving the way for new treatments and therapies. Her contributions are vital in addressing the challenges posed by chronic complications of diabetes.